Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 1:4:203.
doi: 10.3389/fonc.2014.00203. eCollection 2014.

Genetically engineered mouse models of pituitary tumors

Affiliations
Review

Genetically engineered mouse models of pituitary tumors

David A Cano et al. Front Oncol. .

Abstract

Animal models constitute valuable tools for investigating the pathogenesis of cancer as well as for preclinical testing of novel therapeutics approaches. However, the pathogenic mechanisms of pituitary-tumor formation remain poorly understood, particularly in sporadic adenomas, thus, making it a challenge to model pituitary tumors in mice. Nevertheless, genetically engineered mouse models (GEMMs) of pituitary tumors have provided important insight into pituitary tumor biology. In this paper, we review various GEMMs of pituitary tumors, highlighting their contributions and limitations, and discuss opportunities for research in the field.

Keywords: GEMMs; adenoma; mouse models; pituitary; transgenic mice.

PubMed Disclaimer

References

    1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 101:613–910.1002/cncr.20412 - DOI - PubMed
    1. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery (2006) 59:341–5310.1227/01.NEU.0000223437.51435.6E - DOI - PubMed
    1. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab (2006) 91:4769–7510.1210/jc.2006-1668 - DOI - PubMed
    1. Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol (2011) 7:257–6610.1038/nrendo.2011.40 - DOI - PubMed
    1. Buchfelder M. Management of aggressive pituitary adenomas: current treatment strategies. Pituitary (2009) 12:256–6010.1007/s11102-008-0153-z - DOI - PubMed

LinkOut - more resources